FARGNOLI, MARIA CONCETTA
 Distribuzione geografica
Continente #
NA - Nord America 12.810
AS - Asia 6.831
EU - Europa 6.444
SA - Sud America 953
AF - Africa 108
Continente sconosciuto - Info sul continente non disponibili 21
OC - Oceania 14
Totale 27.181
Nazione #
US - Stati Uniti d'America 12.631
SG - Singapore 3.069
IE - Irlanda 1.834
CN - Cina 1.503
TR - Turchia 867
RU - Federazione Russa 837
BR - Brasile 825
SE - Svezia 810
HK - Hong Kong 805
DE - Germania 701
GB - Regno Unito 537
UA - Ucraina 489
IT - Italia 462
FI - Finlandia 305
VN - Vietnam 214
FR - Francia 147
IN - India 96
CA - Canada 94
ES - Italia 56
MX - Messico 53
CZ - Repubblica Ceca 50
AR - Argentina 47
JP - Giappone 45
BE - Belgio 43
PL - Polonia 41
NL - Olanda 36
ZA - Sudafrica 36
BD - Bangladesh 34
IQ - Iraq 24
LT - Lituania 24
EU - Europa 18
ID - Indonesia 18
MA - Marocco 18
PK - Pakistan 17
CO - Colombia 16
KE - Kenya 16
KR - Corea 16
EC - Ecuador 15
UZ - Uzbekistan 15
JO - Giordania 14
AU - Australia 12
IL - Israele 12
PE - Perù 12
VE - Venezuela 11
AZ - Azerbaigian 10
CL - Cile 10
AT - Austria 9
HN - Honduras 8
PY - Paraguay 8
TN - Tunisia 8
TW - Taiwan 8
HU - Ungheria 7
RO - Romania 7
SA - Arabia Saudita 7
EG - Egitto 6
LB - Libano 6
RS - Serbia 6
UY - Uruguay 6
AE - Emirati Arabi Uniti 5
CR - Costa Rica 5
GE - Georgia 5
KG - Kirghizistan 5
KZ - Kazakistan 5
MY - Malesia 5
NP - Nepal 5
TT - Trinidad e Tobago 5
AL - Albania 4
BY - Bielorussia 4
CH - Svizzera 4
DK - Danimarca 4
DZ - Algeria 4
JM - Giamaica 4
LU - Lussemburgo 4
EE - Estonia 3
KH - Cambogia 3
MD - Moldavia 3
MK - Macedonia 3
OM - Oman 3
SK - Slovacchia (Repubblica Slovacca) 3
SN - Senegal 3
AO - Angola 2
CY - Cipro 2
GM - Gambi 2
GR - Grecia 2
GT - Guatemala 2
LC - Santa Lucia 2
ME - Montenegro 2
MN - Mongolia 2
PA - Panama 2
TH - Thailandia 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AD - Andorra 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BF - Burkina Faso 1
BG - Bulgaria 1
BM - Bermuda 1
BO - Bolivia 1
BW - Botswana 1
Totale 27.151
Città #
Chandler 1.944
Jacksonville 1.918
Dublin 1.831
Singapore 1.650
Dallas 1.587
Hong Kong 799
Santa Clara 775
Boardman 691
Ashburn 454
Izmir 424
New York 339
Nanjing 337
Lawrence 306
Princeton 306
San Mateo 304
Wilmington 297
Moscow 219
The Dalles 181
Los Angeles 157
Ann Arbor 156
Beijing 141
Milan 123
Munich 123
Woodbridge 113
Nanchang 108
Columbus 103
Hefei 97
São Paulo 93
Des Moines 86
Mountain View 80
Seattle 74
Shenyang 73
Council Bluffs 67
Helsinki 64
Ho Chi Minh City 59
Tianjin 57
Hebei 55
Verona 54
L'aquila 50
Falls Church 48
Hanoi 47
Brno 45
Brussels 43
Kunming 42
Tokyo 42
Jiaxing 41
Brooklyn 40
Jinan 40
London 40
Stockholm 38
Warsaw 38
Dearborn 37
Rome 37
Dong Ket 35
Montreal 35
Norwalk 34
Shanghai 33
Boston 30
Atlanta 29
Changsha 29
Denver 29
Falkenstein 29
Ningbo 29
Turku 28
Orem 27
San Francisco 26
Amsterdam 25
Houston 25
Belo Horizonte 24
Phoenix 24
Johannesburg 23
Guangzhou 22
L’Aquila 22
Zhengzhou 22
Chicago 20
Rio de Janeiro 20
Ankara 19
Brasília 19
Frankfurt am Main 19
Lappeenranta 19
Mexico City 19
Bremen 18
Manchester 18
Pune 18
Chennai 17
Fremont 17
San Jose 17
Changchun 16
Nuremberg 16
Taizhou 16
Hangzhou 15
Nairobi 15
Toronto 15
Amman 13
Jakarta 13
Poplar 13
Tappahannock 13
Tashkent 13
Baghdad 12
Montesilvano Marina 12
Totale 17.875
Nome #
Cutaneous metastatic breast carcinoma: A study of 164 patients 203
Heterogeneity of BRAF, NRAS, and TERT Promoter Mutational Status in Multiple Melanomas and Association with MC1R Genotype: Findings from Molecular and Immunohistochemical Analysis 156
Rapid response of scalp psoriasis to ustekinumab 138
Characterization of melanoma susceptibility genes in high-risk patients from Central Italy 126
Staging and follow-up of cutaneous Melanoma patients 126
Real-life efficacy and safety of ingenol mebutate for the treatment of actinic keratosis of the face and scalp: A single arm retrospective study 125
Evaluating the role of FAMIly history of cancer and diagnosis of multiple neoplasms in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: the multicenter FAMI-L1 study 123
A variant in FTO shows association with melanoma risk not due to BMI 122
Intra-patient Heterogeneity of BRAF and NRAS Molecular Alterations in Primary Melanoma and Metastases 122
Long-term efficacy and safety of daylight photodynamic therapy with methyl aminolevulinate for actinic keratosis of the face and scalp 120
Current psoriasis treatments in an Italian population and their association with socio-demographical and clinical features 118
Dermoscopic patterns of acral melanocytic nevi and melanomas in a white population in central Italy 117
Understanding the molecular genetics of basal cell carcinoma 117
T-cell receptor (TCR) signal transduction: Biochemical mechanisms and possible clinical implications 116
EDNRB gene variants and melanoma risk in two southern European populations. 116
Cutaneous manifestations in Italian kidney transplant recipients 116
The first skin cancer screening day at the Italian parliament: a Euromelanoma initiative 113
Parapsoriasi 112
The oncogenic neurotrophin receptor tropomyosin-related kinase variant, TrkAIII 111
The role of insomnia in the vulnerability to depressive and anxiety symptoms in atopic dermatitis adult patients 110
Dermoscopic features of actinic keratosis 110
European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 2. Treatment 110
Cutaneous and mucosal melanomas of uncommon sites: Where do we stand now? 110
A multicenter study of skin toxicity management in patients with left-sided, RAS/BRAF wild-type metastatic colorectal cancer treated with first-line anti-EGFR-based doublet regimen: is there room for improvement? 110
The Alternative TrkAIII Splice Variant, a Targetable Oncogenic Participant in Human Cutaneous Malignant Melanoma 108
Telomeres and telomerase in cutaneous squamous cell carcinoma 108
Melanoma in children and adolescents: analysis of susceptibility genes in 123 Italian patients 108
Short-term effectiveness of guselkumab in psoriatic arthritis patients and axial involvement: results from a real-life multicentre cohort 107
Contribution of melanocortin-1 receptor gene variants to sporadic cutaneous melanoma risk in a population in central Italy: a case-control study 107
MC1R variants predisposing to concomitant primary cutaneous melanoma in a monozygotic twin pair 107
A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: When overweight becomes favorable 107
Molecular alterations in basal cell carcinoma subtypes 107
HLA-C*06:02 Does Not Predispose to Clinical Response Following Long-Term Adalimumab Treatment in Psoriatic Patients: A Retrospective Cohort Study 106
MC1R Variants Increase Risk of Melanomas harboring BRAF Mutations 106
Pigmented reticular structures in basal cell carcinoma and collision tumours 105
Genetic profiling of a rare condition: co-occurrence of albinism and multiple primary melanoma in a Caucasian family 105
Early stage melanoma diagnosis and mental health-related: emotional influence of body self-perception 105
Efficacy evaluation of an oil-in-water emulsion (Dermoflan) in atopic dermatitis 104
On the interplay of telomeres, nevi and the risk of melanoma 104
Exploring the interplay of atopic dermatitis severity with sleep and mental health: a case-control study in adult patients 103
Diminished TCR signaling in cutaneous T-cell Iymphoma is associated with decreased activities of Zap70, Syk and membrane-associated Csk 103
Efficacy, tolerability and cosmetic acceptabilily of Toléderm® in patients with inflammatory cutaneous diseases of the face 102
MC1R variants increase melanoma risk in families with CDKN2A mutations: a meta-analysis 102
Mucosal involvement in a patient with lymphomatoid papulosis 102
Risk of second primary malignancies among 1537 melanoma patients and risk of second primary melanoma among 52 354 cancer patients in Northern Italy 102
Physicians' concerns towards prescription adherence and treatment effectiveness in the clinical management of actinic keratosis 101
Frequency of melanocytic nevi in psoriatic patients is related to treatment and not to disease severity 101
Safe Administration of Ipilimumab, Pembrolizumab, and Nivolumab in a Patient with Metastatic Melanoma, Psoriasis, and a Previous Guillain-Barré Syndrome 101
MC1R gene variants and non-melanoma skin cancer: A pooled-analysis from the M-SKIP project 101
Identification of four novel melanocortin 1 receptor (MC1R) gene variants in a Mediterranean population 100
Treatments of advanced basal cell carcinoma: a review of the literature 100
The spectrum of dermatoscopic patterns in blue nevi 100
Genetic Susceptibility In Familial And Multiple Melanoma Patients In Central Italy 100
Conventional vs. daylight methyl aminolevulinate photodynamic therapy for actinic keratosis of the face and scalp: An intra-patient, prospective, comparison study in Italy 100
Efficacy of treatment with tetracyclines to prevent acneiform eruption secondary to cetuximab therapy 99
Meta-analysis of risk factors for cutaneous melanoma according to anatomical site and clinico-pathological variant 99
Reduced expression of CDKN2a/p16INK4a in mycosis fungoides 99
Biotech on the Rise: The Treatment of Psoriasis with Biological Drugs 99
Nucleotide diversity and population differentiation of the melanocortin 1 receptor gene, MC1R 99
Clinical experience of imiquimod 3.75% for actinic keratosis: Results from a case series 99
Dermoscopic features of cutaneous melanoma are associated with clinical characteristics of patients and tumours and with MC1R genotype 98
Early Diagnosis of Melanoma and Breast Cancer in Women: Influence of Body Image Perception 97
Hypo-epiluminescence microscopy of pigmented skin lesions. A new approach to improve recognition of dermoscopic structures 97
CDKN2A/p16 expression in mycosis fungoides 97
Dermoscopic variability of basal cell carcinoma according to clinical type and anatomic location 97
Clinical, dermoscopic, and confocal features of nevi and melanomas in a multiple primary melanoma patient with the MITF p.E318K homozygous mutation 97
Basal cell carcinoma and inflammation: role of the Gadd45b gene 97
European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment – Update 2019 97
MC1R, SLC45A2 and TYR genetic variants involved in melanoma susceptibility in Southern European populations: Results from a Meta-analysis 96
A 48-week update of a multicentre real-life experience of dupilumab in adult patients with moderate-to-severe atopic dermatitis 96
Expression of IL-23/Th17-related cytokines in basal cell carcinoma and in the response to medical treatments 95
Dermoscopic similarity is an independent predictor of BRAF mutational concordance in multiple melanomas 95
Association of Genetic Variants in CDK6 and XRCC1 with the Risk of Dysplastic Nevi in Melanoma-Prone Families 94
Molecular genetic aspects of cutaneous melanoma 93
Mycosis fungoides. Clinical and molecular biology observations 93
Dermoscopic evolution of a congenital combined nevus in childhood 93
Rare missense variants in POT1 predispose to familial cutaneous malignant melanoma 92
Dermatoscopy of basal cell carcinoma: morphologic variability of global and local features and accuracy of diagnosis 92
Use of recombinant interferon alpha-2a in the treatment of squamous cell carcinoma 92
Acneiform follicular mucinosis of the head and neck region 92
A cost-utility analysis of etanercept for the treatment of moderate-to-severe psoriasis in Italy 92
Knowledge of melanoma and attitude towards moles in Italian melanoma 92
Family history of psoriasis and age at disease onset in Italian patients with psoriasis 92
Granulomatous mycosis fungoides responsive to gemcitabine 91
DIMINISHED ACTIVITY OF MEMBRANE-BOUND P50(CSK) IN CUTANEOUS T-CELL LYMPHOMA 91
Unusually large cutaneous metastases of renal cell carcinoma 91
Clinical Trial on Aveeno Skin Relief Moisturizing Lotion in patients with itching accompanied by skin lesions and xerosis 91
Photodynamic therapy for basal cell carcinoma 91
Coding and noncoding somatic mutations in candidate genes in basal cell carcinoma 91
Dermoscopic features and follow-up changes of acral melanocytic naevi in childhood and dolescence. 90
Strategy for in vitro and ex-vivo testing of neutrophins signaling pathways based on immunoproteomic array profiling 90
Efficacy and tolerability of 5-aminolevulinic acid 0.5% liposomal spray and intense pulsed light in wrinkle reduction of photodamaged skin 90
Rationale for the development of speckled hyperpigmentation in the areas of psoriatic plaques after treatment with biologic agents 90
Photodynamic therapy for the treatment of micro invasive squamous cell carcinoma of the lower lip: a case report 90
Multiple microsatellite alterations on chromosome 9 in neurofibromas of NF-1 patients 90
Use of recombinant interferon alfa-2b in the treatment of basal cell carcinoma 90
MC1R variants increased the risk of sporadic cutaneous melanoma in darker-pigmented Caucasians: a pooled-analysis from the M-SKIP project 89
Association of psoriasis and/or psoriatic arthritis with autoimmune diseases: the experience of two Italian integrated Dermatology/Rheumatology outpatient clinics. 89
p16(INK4a) and pl9(ARF) germline mutations in familial melanoma 89
Preliminary observations on the use of topical tazarotene to treat basal-cell carcinoma 88
Totale 10.360
Categoria #
all - tutte 135.419
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 135.419


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.433 0 0 0 0 0 92 304 68 289 99 452 129
2021/20221.694 96 128 308 108 56 39 23 104 175 17 131 509
2022/20235.428 394 290 94 546 454 608 4 399 2.354 31 173 81
2023/20241.397 210 67 147 204 88 355 42 52 1 64 31 136
2024/20256.230 165 108 590 222 734 573 902 480 1.440 200 450 366
2025/20265.690 540 1.061 1.118 1.346 1.190 435 0 0 0 0 0 0
Totale 27.676